tldrdaily.news logo

Eolo Pharma's New Obesity Drug Promotes Fat Burn Without Appetite Suppression

1 min read
Source: WIRED
Eolo Pharma's New Obesity Drug Promotes Fat Burn Without Appetite Suppression
Photo: WIRED
TL;DR Summary

A new experimental obesity drug called SANA, derived from salicylate, may promote weight loss by increasing energy expenditure through creatine-dependent thermogenesis without suppressing appetite, showing promising results in a small human trial and offering a potential alternative to current GLP-1 based treatments.

Topics:top-news#creatine-thermogenesis#health#obesity#pharmacology#sana#weightloss
Share this article
  1. A New Obesity Pill May Burn Fat Without Suppressing Appetite  WIRED
  2. Eolo Pharma Publishes First-in-Human Study in Nature Metabolism on Novel Obesity Drug Activating Energy-Burning Pathway  Yahoo Finance

Reading Insights

Total Reads

0

Unique Readers

1

Time Saved

5 min

vs 6 min read

Condensed

96%

1,002 → 42 words

Want the full story? Read the original article

Read on WIRED